Latest News
Statin Use Reduces Dementia Risk After Concussion in Seniors
North Carolina Sues Electronic Cigarette Maker JUUL
Guidance Issued for Systems of Care for Stroke
Physical Disease, Inflammation Linked to Suicide Risk in Depression
SSc-PAH Risk Category Improves With Ambrisentan and Tadalafil Combo Therapy
Dry Powder Formulation of Treprostinil Appears Safe, Tolerable in PAH
Pulmonary Hypertension Survival Predicted by Cardiopulmonary Reserve Index
Improvements in PAH When Transitioned From PDEi to Riociguat
Familial Hypercholesterolemia Needs Aggressive Lipid-Lowering Therapy After MI
PAH Prognosis Affected by Connective Tissue Disease-PAH Etiology
Echocardiographic Right Atrial Area Improves Survival Prediction in PAH
Rehabilitation After Ischemic Stroke Varies in Acute Care
Cost-Effectiveness of Increased Influenza Vaccination to Reduce MACE Readmission Risk
Higher MACCE Risk in PCI With Persistent High RIR and Low Baseline LDL
Latest Features
Cardiovascular Risk in Pediatric Obstructive Sleep Apnea: What Do We Know?
A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.
Drug-Induced Pulmonary Arterial Hypertension: A More Complicated Prognosis
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
Excipients in Medications May Trigger Adverse Reactions in Some Patients
A team of investigators from both Brigham and Women’s Hospital and the Massachusetts Institute of Technology analyzed data on thousands of inactive ingredients in approved medications to further characterize them and enhance our knowledge of their safety.
